Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. En savoir plus sur Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study.
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance. En savoir plus sur Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D''Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study. En savoir plus sur Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D''Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study. En savoir plus sur Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.
Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study. En savoir plus sur Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study.
Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery. En savoir plus sur Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.
Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies. En savoir plus sur Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features. En savoir plus sur Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction. En savoir plus sur Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.
Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies. En savoir plus sur Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies.